Clinical trial
Changes in the Prevalence of Oncogenic HPV Types After Introduction of Prophylactic HPV Vaccine Program in Japan
NCT04671823 is registered in ClinicalTrials.gov with Kanazawa Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Changes in the Prevalence of Oncogenic HPV Types After Introduction of Prophylactic HPV Vaccine Program in Japan
- Lead sponsor
- Kanazawa Medical University
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- December 31, 2020
- Completion date
- March 31, 2022
- Enrollment
- 1,500 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
papillomavirus infections, papillomavirus vaccines